HIV Emergency Relief Project Grants


To provide direct financial assistance to Eligible Metropolitan Areas (EMAs) and Transitional Grant Areas (TGAs) that have been the most severely affected by the Human Immunodeficiency Virus (HIV) epidemic to enhance access to a comprehensive, effective and cost efficient continuum of high quality, community-based care for low-income individuals and families with HIV and to strengthen strategies to reach minority populations. A comprehensive continuum of care includes the 13 core medical services specified in legislation and appropriate support services that assist People Living With HIV/AIDS (PLWH/A) in accessing treatment for HIV/AIDS infection that is consistent with the Department of Health and Human Service (HHS) Treatment Guidelines. Comprehensive HIV/AIDS care beyond these core medical services may include supportive services that meet the criteria of enabling individuals and families living with HIV/AIDS to access and remain in primary medical care to improve their medical outcomes.

General information about this opportunity
Last Known Status
Program Number
Federal Agency/Office
Agency: Department of Health and Human Services
Office: Health Resources and Services Administration
Type(s) of Assistance Offered
Project Grants
Program Accomplishments
Not Applicable.
Sections 2601-2610 of Title XXVI of the Public Health Service Act, (42 USC 300ff-11 – 300ff-20), as amended by the Ryan White HIV/AIDS Treatment Extension Act of 2009 (Public Law 11-87).
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Part A Recipients that were classified as an EMA or as a TGA in fiscal year (FY) 2007 and continue to meet the statutory requirements are eligible to apply for these funds. For an EMA, this is more than 2,000 cases of AIDS reported and confirmed during the most recent 5 calendar years, and for a TGA, this is at least 1,000, but fewer than 2,000 cases of AIDS reported and confirmed during the most recent period of 5 calendar years for which such data are available. Additionally, they must not have fallen below, for three consecutive years, the required incidence levels already specified AND required prevalence levels (cumulative total of living cases of AIDS reported to and confirmed by the Director of the CDC as of December 31 of the most recent calendar year for which such data are available). For an EMA, this is 3,000 living cases of AIDS, and for a TGA, this is 1,500 living cases of AIDS, except certain areas which have a cumulative total of at least 1,400 living cases of AIDS and which have no more than 5 percent of the total from formula grants awarded unobligated as of the end of the most recent fiscal year..

Eligible metropolitan areas (EMA) with a population of 50,000 or more individuals for which the Centers for Disease Control and Prevention has reported a cumulative total of more than 2,000 AIDS cases for the most recent period of 5 calendar years include: Atlanta, Georgia; Baltimore, Maryland; Boston, Massachusetts; Chicago, Illinois; Dallas, Texas; Detroit, Michigan, Ft. Lauderdale, Florida; Houston, Texas; Los Angeles, California; Miami, Florida; Nassau/Suffolk Counties, New York; New Haven, Connecticut; New Orleans, Louisiana; New York, New York; Newark, New Jersey; Orlando, Florida; Philadelphia, Pennsylvania; Phoenix, Arizona; San Diego, California; San Francisco, California; San Juan, Puerto Rico; Tampa-St. Petersburg, Florida; Washington, DC; and West Palm Beach, Florida. Transitional Grant areas (TGA) with a population of 50,000 or more individuals for which the Centers for Disease Control and Prevention has reported a cumulative total of at least 1,000, but not more than 1,999 AIDS cases for the more most recent five year period include: Austin, Texas; Baton Rouge, Louisiana; Bergen-Passaic, NJ; Charlotte, North Carolina; Cleveland, Ohio; Columbus, Ohio; Denver, Colorado; Fort Worth, Texas; Hartford, Connecticut; Indianapolis, Indiana; Jacksonville, Florida; Jersey City, New Jersey; Kansas City, Missouri; Las Vegas, Nevada; Memphis, Tennessee; Middlesex, New Jersey; Minneapolis, Minnesota; Nashville, Tennessee; Norfolk, Virginia; Oakland, California; Orange County, California; Ponce, Puerto Rico; Portland, Oregon; Riverside-San Bernardino, California; Sacramento, California; St. Louis, Missouri; San Antonio, Texas; San Jose, California; and Seattle, Washington.
Beneficiary Eligibility
Individuals and families with HIV disease will benefit.
Applicants should review the individual HRSA funding opportunity announcement issued under this CFDA program for any required proof or certifications which must be submitted prior to or simultaneous with submission of an application package. 2 CFR 200, Subpart E - Cost Principles applies to this program.
What is the process for applying and being award this assistance?
Pre-Application Procedure
Preapplication coordination is required. Environmental impact information is not required for this program. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review.
Application Procedure
2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. HRSA requires all applicants to apply electronically through
Award Procedure
Two-thirds of the funds available are disbursed on a formula basis as required by the legislation, subject to a completeness review of required information specified in the HRSA funding opportunity issued under this CFDA program. The remaining one-third of available funds are disbursed as a competitive, supplemental grant, based on criteria specified by the legislation. All qualified applications will be forwarded to an objective review committee. Based on the recommendations of the objective review committee, the HRSA program official with delegated authority is responsible for final selection and funding decisions. In addition, Minority AIDS Initiative (MAI) funds available under Section 2693 are disbursed on a formula basis together with the Formula and Supplemental awards as required by the legislation. Notification is made in writing by a Notice of Award.
Contact the headquarters or regional office, as appropriate, for application deadlines.
Approval/Disapproval Decision Time
About 60 days.
Not Applicable.
Not Applicable.
How are proposals selected?
Applications for supplemental funds must meet nine criteria set forth in the enacting legislation: (1) Contain a report concerning the dissemination of emergency relief funds and the plan for utilization of such funds; (2) demonstrate need in such area for supplemental financial assistance to combat the HIV epidemic; (3) demonstrate the existing commitment of local resources of the area, both financial and in-kind, to combat the HIV epidemic; (4) demonstrate the ability of the area to utilize such supplemental financial resources in a manner that is immediately responsive and cost-effective; (5) demonstrate that resources will be allocated in accordance with the local demographic incidence of AIDS including appropriate allocations for services for infants, children, women, and families with HIV disease; (6) demonstrate the inclusiveness of affected communities and individuals with HIV disease; (7) demonstrate the manner in which proposed services are consistent with the local needs assessment and the statewide coordinated statement of need; (8) demonstrate the ability of the applicant to expend funds efficiently by not having had, for the most recent Part A formula grant year for which data is available, more than 5 percent of grant funds unobligated at the end of the year, even if a request for carryover was granted; and (9) demonstrate success in identifying individuals with HIV and AIDS, who are unaware of their HIV/AIDS status, and provides a description of the Strategy, Plan, and Data associated with the early identification of these individuals.
How may assistance be used?
Funds received under a grant are to be used to fund not less than 75 percent core medical services and 25 percent support services, unless a waiver request related to this requirement is submitted and approved. Core medical services include: outpatient and ambulatory health services, AIDS Drug Assistance Program, AIDS pharmaceutical assistance, oral health care, early intervention services, health insurance premium and cost-sharing for low-income individuals, home health care, medical nutritional therapy, hospice services, home and community-based health services as defined under Section 2614 (c), mental health services, substance abuse outpatient care, and medical case management, including treatment adherence services. Support services are for individuals with HIV/AIDS to achieve medical outcomes and may include respite care for persons caring for individuals with HIV/AIDS, outreach services, medical transportation, linguistic services and referral for health care and support services, and others. A percentage of the grant, determined by the percentage of women, infants, children and youth in the area with HIV/AIDS, will be used to provide health and support services to women, infants, children, and youth with HIV disease, including treatment measures to prevent the perinatal transmission of HIV. No more than 10 percent of amounts received under a grant may be used to fund the recipient’s grant administration and monitoring activities, program support activities and all activities associated with recipient contract award procedures. In addition, sub-recipient level administrative expenses may not exceed 10 percent of aggregate expenditures (without regard to whether particular entities expend more than 10 percent for such administrative expenses). Recipients may use up to 5 percent of funds or $3 million, whichever is less, for clinical quality management activities to assess the extent to which HIV health services provided to patients under the grant are consistent with the most recent Department of Health and Human Services guidelines for the treatment of HIV/AIDS. Funds may not be used to make payments for any item or service to the extent that payment has been made, or can reasonably be expected to be made, with respect to that item or service by other public or private insurance programs, or any entity that provides health services on a prepaid basis (except for a program administered by or providing the services to the Indian Health Service). Funds may not be used to purchase or improve land, or to purchase, construct or make permanent improvement to any building except for minor remodeling. Funds may not be used to make payments to recipients of services.
What are the requirements after being awarded this opportunity?
Annual progress and annual financial reports are required. Quarterly financial cash transaction reports are required within 30 days of the end of each calendar quarter. Annual reports are to be submitted within 90 days after the end of each budget period. The final performance report and final financial status reports are due 90 days from the end of the project period. Reports documenting services and expenditures are required. Recipients must report expenditures for WICY for the previous budget year within 150 days of the end of the grant year as mandated by the Ryan White HIV/AIDS Program. Recipients must submit a Federal Financial Report (FFR) or SF 245 within 120 days after the end of the budget period.
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.
Recipients are required to maintain grant accounting records 3 years after the date they submit the Federal Financial Report (FFR). If any litigation, claim, negotiation, audit or other action involving the award has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular 3-year period, whichever is later.
Other Assistance Considerations
Formula and Matching Requirements
Statutory Formula: Part A grants to EMAs and TGAs include formula and supplemental components as well as Minority AIDS Initiative (MAI) funds, which supports access to services targeting minority populations.

Statutory Formula: The formula portion of the grant is determined by the number of living cases of HIV/AIDS in each eligible area as reported to and confirmed by the Centers for Disease Control and Prevention by December 31 for the most recent calendar year for which data is available. As of FY 2013 and beyond, formula awards will be based ONLY on name-based data. Name-based reporting is defined as the number of living name-based cases of HIV/AIDS reported to the Centers for Disease Control and Prevention (CDC) as of December 31 of the most recent calendar year for which data is available.

Supplemental grants are awarded competitively on the basis of demonstrated need and other criteria. [See Criteria for Selecting Proposals (180)].

MAI formula funds are based on the number of reported and confirmed living minority cases of HIV/AIDS for the most recent calendar year.
Matching requirements are not applicable to this program.
This program has MOE requirements, see funding agency for further details. The Ryan White HIV/AIDS Program legislation requires Part A recipients to maintain, as a Condition of Award, political subdivision expenditures within the eligible area for HIV-related Core Medical Services and Support Services at a level equal to the 1-year period preceding the fiscal year for which the grantee is applying to receive a Part A grant.
Length and Time Phasing of Assistance
Grants are awarded for a 12-month budget period. See the following for information on how assistance is awarded/released: Recipients drawdown funds, as necessary, from the Payment Management System (PMS). PMS is the centralized web based payment system for HHS awards.
Who do I contact about this opportunity?
Regional or Local Office
See Regional Agency Offices.
Headquarters Office
Steven Young, Director 5600 Fishers Lane, Room 9W12, Rockville, Maryland 20857 Phone: (301) 443-7136
Website Address
Financial Information
Account Identification
(Project Grants) FY 14 $618,492,359; FY 15 est $624,704,781; and FY 16 est $620,079,915
Range and Average of Financial Assistance
For 2015: Range = $2,097,353 - $102,094,291; Average = $11,786,883.
Regulations, Guidelines and Literature
Effective December 26, 2014, all administrative and audit requirements and the cost principles that govern federal monies associated with this award will be subject to the Uniform Guidance 2 CFR 200 as codified by HHS at 45 CFR 75, which supersede the previous administrative and audit requirements and cost principles that govern federal monies.
Examples of Funded Projects
Not Applicable.


Related Federal Grants

Federal Grants Resources